CD274 and malignant colon neoplasm: For the immune checkpoint inhibitor avelumab (indication: Merkel cell carcinoma), an in vivo study using a Merkel cell carcinoma cell line was not conducted, but a growth-inhibitory effect was observed in vivo using a mouse colon cancer-derived MC38 cell line expressing Programmed cell Death ligand 1(PD-L1).